Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2014; 20(16): 4526-4535
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4526
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4526
Figure 2 Median overall survival in months for the four individual human epidermal growth factor receptor 2 immunohistochemistry scores for the two treatment groups.
OS: Overall survival; FC: Fluorouracil/capecitabine plus cisplatin; FC + T: Fluorouracil/capecitabine plus cisplatin plus trastuzumab[10]; FISH: Fluorescence in situ hybridization; IHC: Immunohistochemistry.
- Citation: Jørgensen JT. Role of human epidermal growth factor receptor 2 in gastric cancer: Biological and pharmacological aspects. World J Gastroenterol 2014; 20(16): 4526-4535
- URL: https://www.wjgnet.com/1007-9327/full/v20/i16/4526.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i16.4526